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E-mail address: wolfgang.dubiel@charite.de (W. DThe COP9 signalosome (CSN) is a platform for protein communication in eukaryotic cells. It has an
intrinsic metalloprotease that removes the ubiquitin (Ub)-like protein Nedd8 from cullins. CSN-
mediated deneddylation regulates culling-RING Ub ligases (CRLs) and controls ubiquitination of pro-
teins involved in DNA damage response (DDR). CSN forms complexes with CRLs containing cullin 4
(CRL4s) which act on chromatin playing crucial roles in DNA repair, checkpoint control and chroma-
tin remodeling. Furthermore, via associated kinases the CSN controls the stability of DDR effectors
such as p53 and p27 and thereby the DDR outcome. DDR is a protection against cancer and deregu-
lation of CSN function causes cancer making it an attractive pharmacological target. Here we review
current knowledge on CSN function in DDR.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The COP9 signalosome was discovered in 1996 as a negative
regulator of Constitutive Photomorphogenesis (COP) in plants [1].
Two years later the CSN was independently rediscovered in human
red blood cells [2] and in pig spleen [3] and it became clear that the
complex function is beyond the regulation of light-dependent reac-
tions in plants. In the past years the CSN was identiﬁed in all
eukaryotic cells studied including Saccharomyces cerevisiae [4,5],
Schizosaccharomyces pombe [6], Aspergillus nidulans [7], Caenorhab-
ditis elegans [8] and Drosophila melanogaster [9]. Already in 1998 it
was demonstrated that CSN subunits possess signiﬁcant sequence
homologies with subunits of the 26S proteasome lid subcomplex
[2,10,11]. In addition, similarities with the translation initiation
complex 3 (eIF3) were identiﬁed [12]. The three complexes (CSN,
lid and eIF3) are composed of (Proteasome, COP9 signalosome, Ini-
tiation factor eIF3) PCI-domain and (MOV34, Pad1N-terminal)
MPN-domain subunits and most likely possess a common ancestor
during evolution [13]. In recent years they were summarized as
‘‘Zomes’’ complexes.
According to the uniﬁed nomenclature the typically eight CSN
subunits were designated as CSN1 to CSN8 [14]. Each subunit
was identiﬁed as a binding surface of many different interacting
regulatory proteins (for recent review see [15]). Whether all of
these interactions are speciﬁc and exhibit biological relevanceal Societies. Published by Elsevier
ubiel).has to be elucidated in the future. In the course of this review we
will characterize a number of speciﬁc CSN interactions. Knockouts
of CSN subunit genes in yeast are viable (for review see [16]). In A.
nidulans knockouts are viable but can induce a DDR phenotype
[17]. In contrast, knockouts of any of the eight CSN subunits in
mice are lethal at an early stage of embryonic development [18–
21]. These data reﬂect the increasing signiﬁcance gained by the
CSN during evolution of multi-cellular organisms. The biological
function of the CSN is mostly determined by regulating CRLs, the
largest family of E3s of the Ub proteasome system (UPS) [22,23].
CRLs are responsible for the poly-ubiquitination and subsequent
degradation of many regulatory proteins of cell cycle progression,
signal transduction and development (for review see [15,16,24]).
Interestingly, the ﬁrst hint that the CSN is involved in DDR was
the observation that S. pombe Csn1 and Csn2 mutants displayed a
delay in S phase progression and were hypersensitive to UV- and
c-irradiation [6]. In contrast, deletions of Csn4 and Csn5 behaved
like wild type (wt) [25]. Because all cells either lacking CSN1,
CSN2, CSN4 or CSN5 showed the same cullin 1 (Cul1)/Pcu1
hyper-neddylation phenotype, a distinct function of these subunits
besides deneddylation of Cul1/Pcu1 was indicated [25]. Later a de-
fect in Spd1p degradation, an inhibitor of ribonucleotide reductase,
was shown to be the reason for the S. pombe phenotypes, because
the enzyme is especially needed in S phase and for DNA repair [26].
Interestingly, Spd1p is degraded by a CRL using cullin 4 (Cul4) as a
scaffold (CRL4). Why this depends on CSN1 and CSN2 but not on
CSN3 and CSN4 is still not clear. In contrast to S. pombe, there is
no delay in S phase in the budding yeast S. cerevisiae after CSNB.V. Open access under CC BY-NC-ND license.
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ever, homologs of CSN1 or CSN2 are not clearly identiﬁable in these
species [4] and levels of overall sequence identity between sub-
units from budding yeast and those from other organisms are ex-
tremely low [27]. On the other hand, the CSN is involved in DDR
in A. nidulans [17] and in D. melanogaster [28]. It could be unequiv-
ocally shown that deletion of Csn4 or Csn5 in D. melanogaster led to
hypersensitivity to methylmethane sulfonate, a DNA methylating
agent, suggesting a role of the CSN in DDR in insects. Groisman
et al. have shown that the CSN differentially regulates CRLs in-
volved in the repair process in mammalian cells [29]. Through con-
trol of a special subset of CRL4s the CSN expands its functional
importance on chromatin remodeling and DNA repair. This review
focuses on recent discoveries regarding the role of the CSN in DDR.2. Multiple faces of the CSN
2.1. The architecture of the CSN in different species
There are variations of CSN subunit composition in different
species responsible for structure and function of the complex.
The S. cerevisiae complex consists of Rri1, a real CSN5 homolog,
and of additional four subunits (CSN9, CSN10, CSN11 and Csi1)
possessing few similarities to subunits in higher eukaryotes [5].
Recently it has been shown that the proteasomal subunit Rpn5
has a dual function in the 26S proteasome and in the CSN [30]. An-
other situation has been described for S. pombe. The ﬁssion yeast
CSN is composed of CSN1, CSN2, CSN3, CSN4, CSN5 and CSN7a,
whereas CSN7b is a subunit of the eIF3 complex. Subunits 6 and
8 are missing in S. pombe [31]. In C. elegans the CSN shares one sub-
unit with eIF3 complex, which is called CIF-1 [32]. In A. thaliana
CSN5 and CSN6 are each encoded by two very homologous genes,
Csn5a and Csn5b or Csn6a and Csn6b [31,33]. In mammalian cells
CSN7 occurs as CSN7a and CSN7b most likely as components of dif-
ferent CSN complexes [34]. Recent systematic proteomic analysis
of the mammalian CSN demonstrated that CSN7b is not part of
CSN7a-containing complexes [35] indicating that CSN7a and
CSN7b are indeed components of different CSN complexes.
The architecture of the human CSN was ﬁrst studied by electron
microscopy (EM) [36]. EM images of the human CSN and lid re-
vealed similar architectures. The two particles occurred in different
classes indicating structural diversity most likely due to changes in
subunit composition (CSN7a or CSN7b), association of various pro-
teins (for example USP15 or kinases) and/or CSN subunit modiﬁca-
tions presumably by phosphorylation. Using CSN EM images and
known subunit–subunit interactions a ﬁrst model of the CSN was
created ([36], see Fig. 1). Recently a new model has been proposed
based on an emerging mass spectrometry approach [37]. In this
study Sharon et al. found that the structure of the complex is ar-
ranged by two symmetrical clusters/modules, CSN1/2/3/8 and
CSN4/5/6/7, connected by a single link via CSN1–CSN6. Within
each cluster the two most conserved subunits, CSN2 and CSN5, oc-
cupy a peripheral position. The model also revealed remarkable
structural similarities with the 19S lid [37]. Another three-dimen-
sional structure of the CSN was proposed based on negative stain
EM and single particle analysis. The comparison with the lid and
the eIF3 complexes revealed a conserved architecture implying
similar assembly pathways [38]. Unfortunately, there exist neither
cryo-EM data nor crystal structure of the CSN complex. There are
no structural data on CSN-based supercomplexes.
2.2. Is the CSN just a deneddylase?
CSN-mediated deneddylation located to CSN5 but requiring the
entire CSN complex is probably the most prominent biochemicalactivity of the CSN. The metalloprotease JAMM/MPN+ motif of
CSN5 possesses the His-X-His-X10-Asp consensus sequence (where
X indicates any residue) accompanied by an upstream conserved
Glu [39]. The CSN5 paralog subunit of the 26S proteasome lid is
S13/Rpn11, which is a deubiquitinating enzyme and essential for
26S proteasome functioning [40–43]. The JAMM/MPN+ motif is a
typical Zn2+-binding metalloprotease domain, which can be
blocked by Zn2+ chelators such as o-phenanthroline. The CSN spe-
ciﬁcally removes Nedd8 from isopeptide bonds. It does not cleave
Nedd8-AMC or Nedd8 linear extensions indicating that the CSN is
unable to process pre-Nedd8 [44]. The deneddylating activity of
the CSN can be knocked out by point mutations in the JAMM/
MPN+ motif [29,39]. A conditional knockout of Csn5 in T cells
inhibited cell cycle and led to an increase of b-catenin [45]. Inter-
estingly, CSN5 is overexpressed in many tumor cells [46,47].
Cullins are the major substrates of CSN-mediated deneddyla-
tion. In mammals Cul1, 2, 3, 4A, 4B, 5, 7 bind to one of the RING do-
main proteins (Rbx1 or Rbx2) [48] at the C-terminus that mediates
E2 interaction. Substrate-speciﬁcity is orchestrated by different
modules that bind to the N-terminus of cullins. Skp1 and an
F-box (FBX) or FBW8 protein assemble into Cul1 and Cul7-based
E3 ligases, respectively. Elongin B/C and VHL-box or SOCS-box
assemble into Cul2/5 and Cul3-based E3 ligases assemble with
Bric-a-brac, Tramtrack, and Broad (BTB) domain proteins repre-
senting both adaptor and substrate receptors. Cul4A/B associate
with the substrate receptor DDB1 and bind to Cul4-associated fac-
tors (DCAFs) [49,50]. Systematic proteomic analysis of the mam-
malian CSN revealed the actual diversity of CSN–CRL interactions
[35,51]. Given the fact that CRLs possess modular structures a large
number of complexes can be formed speciﬁcally targeting thou-
sands of substrates.
CRLs are post-translationally modiﬁed with Nedd8 [22]. Neddy-
lation of cullins leads to a conformational change not only promot-
ing recruitment of Ub-charged E2 but bringing the substrate and
the E2 in close proximity that facilitates Ub transfer [52,53]. The li-
gase is inactivated by CSN-mediated deneddylation [54,55], which,
on the other hand, is essential to prevent degradation/instability of
CRL compounds, in particular, of substrate recognition subunits
[56–59]. Non-neddylated cullins can bind to the cullin associated
neddylation dissociated protein 1 (CAND1/TIP120A) preventing
substrate adaptor/receptor association and blocking the neddyla-
tion site [60]. CAND1 seems to promote a substrate receptor ex-
change and the binding of substrate receptor subunits with low
afﬁnity for Cul1 [59]. Therefore, CSN-mediated deneddylation also
facilitates the CRL reassembly pathway via CAND1. Knockout
experiments in mice suggest that in addition to deneddylation
other functions are carried out by the CSN.
CSN-mediated phosphorylation has been ﬁrst described in 1998
[2]. The CSN is associated with a variety of proteins including the
protein kinases CK2 and PKD [61], Akt [62] as well as inositol
1,3,4-triphosphate 5/6 kinase [63]. The kinases speciﬁcally modify
substrates of the UPS and determine their stability [64]. For exam-
ple, CK2 phosphorylates p53 at Thr155 or modiﬁes p27Kip which
targets the tumor suppressors to degradation by the UPS [62,65].
Just recently a CRL1 has been identiﬁed which ubiquitinates p53
upon CSN-mediated modiﬁcation. The responsible CRL1 uses the
Kelch domain-containing F-box protein JFK [66]. On the other
hand, CSN-mediated phosphorylation of c-Jun stabilizes the tran-
scription factor toward the UPS [61]. The same holds true for the
microtubule end-binding protein 1 (EB1), which is also a substrate
of the UPS [67]. The transcription factor c-Jun is responsible for the
induction of the vascular endothelial growth factor (VEGF) in tu-
mor cells [68], the most important pro-angiogenic regulators in
mammals. CSN associated kinase inhibitors including curcumin
and a number of curcumin-like compounds [69] stabilize the
tumor suppressor p53 and induce UPS-dependent degradation of
Fig. 1. The CSN is involved in DDR. The CSN model shown is based on Kapelari et al. [36]. MPN domain subunits are blue and PCI domain proteins are yellow. The intrinsic
deneddylating activity of the CSN is localized to CSN5. The complex is associated with kinases and with the DUB enzyme USP15. Additional yet unknown activities might
exist. By deneddylation, phosphorylation and deubiquitination the CSN inﬂuences DDR outcome which can be successful DNA repair, activation of checkpoint control,
apoptosis, senescence or activated transcription.
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can be phosphorylated by associated [36,71] or non-associated ki-
nases. Recently the phosphorylation of CSN1 by the glycogen syn-
thase kinase 3b (GSK3b) has been demonstrated being important
for the formation of the CSN-based supercomplex with the b-
catenin destruction complex [72]. In connection with the DNA-
damage-triggered checkpoint control a direct binding of Ataxia-
telagiectasia mutated (ATM) kinase with the CSN has been
observed as a result of a double DNA strand breaks followed by
phosphorylation of CSN3 [73].
CSN-mediated deubiquitination has been ﬁrst described by Grois-
man et al. [29]. These authors showed that the CSN has most likely
two deubiquitinating enzyme (DUB) activities: one that removes
Ub from Cul4A and one activity that depolymerizes Ub chains.
The Ub-speciﬁc protease 15 (USP15, the S. pombe homolog is called
Ubp12) has been identiﬁed as the enzyme that can cleave Ub
chains [74,75]. Since CSN complexes were able to cleave Ub from
Cul4A, it was concluded that the CSN5 metalloprotease might be
responsible for this activity. USP15 is localized to the nucleus as
well as to the cytoplasm and its nuclear import needs functional
CSN [74]. It is a cysteine protease with the typical catalytic triad
Cys, His and Asp and belongs to the family of DUBs. In addition it
has a zinc (Zn)-ﬁnger motif, which is necessary for the binding
and cleavage of Ub chains. The cysteine residue 783 of the Zn-ﬁn-
ger was mutated to alanine and the recombinant mutant USP15-
C783A was unable to cleave Ub lysine 48 chains, although it
removed linear-linked Ub from GFP [75]. USP15 protects proteins
against autoubiquitination and degradation [74,75]. It has been
shown that components of CRLs such as BTB protein or the
RING-protein Rbx1 [59,75] are protected by USP15. In S. pombe
the Btb3p is strongly destabilized in ubp12/USP15 deleted cells
[76]. In addition, components of signaling pathways such as IjBa
[77] and the adenomatous polyposis coli (APC) protein [72] are sta-
bilized by USP15. Although few functions of USP15 have been de-
scribed, its biological signiﬁcance remained obscure.
Since the CSN is not only a deneddylase but also a kinase
complex and a DUB it fulﬁlls multiple jobs which might differ from
species to species or from cell to cell. As a regulator of the UPS theCSN is involved in many cellular processes such as cell cycle,
signal transduction and development (for recent reviews see
[15,16,24,78]).
3. The role of the CSN in the DDR
Cells are constantly threatened by DNA damage due to various
exogenous and endogenous stresses, e.g. chemicals, reactive oxy-
gen species, UV or ionizing radiation (IR). These damages have to
be repaired to assure survival of the cell and proper transmission
of the genetic information to the offspring. Therefore a complex
of signal transduction pathways and cellular responses evolved,
designated as DDR, to counteract DNA damage (extensively re-
viewed in [79]). Importantly, the outcome of this response can be
a delay or arrest in cell cycle (checkpoint activation), transcrip-
tional activation, senescence, apoptosis or ‘mitotic catastrophe’
[80] depending on the context (see Fig. 1). Thus, DDR has to be
tightly regulated and the CSN seems to be an important factor.
3.1. CRL4s and the CSN
Although not all CRL4 ligases are associated with chromatin
[48], an amazing hallmark of most CRL4s is that they concentrate
their work on chromatin. They play crucial roles in DNA repair,
checkpoint control and chromatin remodeling [81,82]. Interest-
ingly, S. cerevisiae has no Cul4 ortholog but its Cul8 assembles to
Cul4-like complexes [48]. Accordingly, Cul8 knockout mutants
are slower in growth and sensitive to fork arrest due to alkylation,
accumulate DNA damage and lose genomic integrity [83,84]. In
higher eukaryotes the substrate speciﬁcity of CRL4s is determined
by DCAFs (see Fig. 2), which usually have WD40 repeats and bind
DDB1 [49]. There are more than 90 predicted DCAFs [85]. However,
it has to be clariﬁed whether all DCAFs mediate substrate
ubiquitination.
Studies have shown that the CRL4 interacting with the substrate
receptor DDB2 (CRL4DDB2) also targets ubiquitination of histones
contributing to the ‘histone code’ similarly like acetylation or
methylation. The post-translational modiﬁcation of histones
Fig. 2. The CSN interacts with different CRL4 complexes involved in DDR. At the
moment the exact mechanism regulating the binding of the CSN to one CRL4 and
then its reassembly into a supercomplex with another CRL4 is not clear. Perhaps the
DDR kinases ATM and ATR are involved in the process by direct phosphorylation of
CSN subunits and/or of CRL4 components.
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factors. At sites of damaged DNA CRL4DDB2 mediates H2A ubiquiti-
nation [86]. Histones H3 and H4 are also ubiquitinated in response
to DNA damage facilitating the recruitment of DNA repair proteins
(XPC) [87]. Skin speciﬁc disruption of Cul4A in mice led to in-
creased resistance to UV-induced carcinogenesis and accumulation
of both DNA damage sensors, DDB2 and XPC, as well as of p21, the
DNA damage checkpoint effector [88]. This results in enhanced glo-
bal genome (GG)-nuclear excision repair (NER, GG-NER) activity
and reinforces UV-responsive G1 DNA damage checkpoint.
3.2. The CSN controls DDR, the impact on nucleotide excision repair
Severe alterations in DNA structure like single strand breaks
(SSBs) or double strand breaks (DSBs) bring cells in acute danger.
DSBs are recognized by the Ku protein and repaired by non-
homologous end-joining (NHEJ) or by the Ku-independent micro-
homology-mediated end-joining (MMEJ) mechanism. Another
possibility to repair DSBs is via homologous recombination (HR)
which depends on homologous sequences, requires sister chromat-
ides as template and therefore only operates in S and G2 of the cell
cycle. HR is also used to restart stalled replication forks and to re-
pair intrastrand crosslinks. UV mainly produces cyclobutane
pyrimidine dimers (CPDs) and (6-4) pyrimidine-pyrimidone (6-
4PPs) photoadducts that are repaired by NER. There are two path-
ways for NER that work either on the whole genome called GG-NER
[89] or the rapid transcription coupled repair (TC-NER) that only
repairs actively transcribed DNA strands. These two NER pathways
mainly differ in the manner how DNA lesions are sensed [90]. Dur-
ing the last decade it could be shown that the CSN controls GG-NER
as well as the TC-NER pathway. There are various hereditary dis-
eases that involve defects in NER: xeroderma pigmentosum (XP)
and cockayne syndrome (CS). Both XP and CS are characterized
by photosensitivity but only XP is attributed to increased incidence
of sunlight induced skin cancer. Importantly, mainly CS patients,
but also patients with other defects in NER display developmental
and neurological aberrations. Remarkably, despite the importance
of NER neurons show attenuated NER activity and other terminally
differentiated tissues [91,92]. In neuronal diseases (e.g. Alzhei-
mer’s disease) it has been shown that neurons re-enter the cell cy-
cle, duplicate their DNA but do not enter mitosis and consequently
undergo apoptosis [93]. Insufﬁcient DNA repair thereby could con-
tribute to neurological disorders. There are seven complementa-
tion groups in XP (XP-A to XP-G) and two in CS (CS-A and CS-B)reﬂecting mutations in excision repair proteins. The DDB2 func-
tions as the damage sensor. DDB2 effectively recognizes and binds
DNA lesions, e.g. CPDs and with highest afﬁnity to 6-4PPs [94,95].
DDB2 is part of a CRL4A. In unperturbed cells the CRL4DDB2 is asso-
ciated with CSN stabilizing the CRL4DDB2 by deneddylation. After
UV irradiation DDB2 rapidly binds to the lesion and unwinds the
DNA inducing a strong kink [96,97]. Now chromatin bound
CRL4DDB2 is no longer associated with the CSN and facilitates ubiq-
uitination. Knockdown of CSN5 results in the reduction of
unscheduled DNA synthesis suggesting that the CSN is a positive
regulator of NER activity [29]. The CRL4DDB2 ligase also mediates
histone ubiquitination around damage sites in vitro [90] promoting
recruitment of another NER protein, XPA [90], probably to loosen
the chromatin [87]. Interestingly, in vitro studies have shown that
DDB2 facilitates its autoubiquitination [98] that lowers its afﬁnity
to lesions [99] and initiates its degradation after UV exposure
[99,100]. Thus, the ligase complex obviously helps to make the
chromatin accessible for NER factors and takes charge of its own
degradation. Recent studies have shown that Ku protein inhibits
extensive DDB2 ubiquitination around damage sites [90]. Together
with XPA the heterotrimeric replication protein A (RPA, binding
ssDNA) and XPC bind to the site of the lesion. XPC preferentially
recognizes 6-4PPs and is also ubiquitinated by the CRL4ADDB2 com-
plex. In contrast to DDB2 it increases afﬁnity for DNA and does not
promote its own degradation [99]. However, Cul4A null MEFs accu-
mulate both DDB2, XPC and p21 DNA damage sensors [101]. More-
over, another study showed proteasomal degradation of XPC
presumably mediated via CRL4A [102]. XPA, RPA and XPC then re-
cruit the transcription factor TFIIH containing two helicases, XPD
and XPB that unwind the DNA. The damaged strand is incised
up- and downstream from the lesion and the DNA gap is ﬁlled by
recruitment of proliferating cell nuclear antigen (PCNA) and subse-
quent binding of replicative polymerases (Pold, Pole). In a last step
the original duplex is restored by ligation.
Interestingly, Cul4A null MEFs not only accumulate DDB2 and
XPC DNA damage sensors, but display dramatically enhanced
GG-NER activity in CPD and 6-4PP removal and reinforce UV-
responsive G1 DNA damage checkpoint [101]. Microinjection of
the puriﬁed DDB2 protein complex into XP-E cells that are defec-
tive in DDB2 completely restored GG-NER [29] as determined by
UV-induced unscheduled DNA synthesis mainly reﬂecting GG-
NER [103].
DNA repair via TC-NER depends on CSA, CSB and XBA2, which
are dispensable for GG-NER. The DNA lesion is sensed by stalled/
blocked RNA polymerase II (RNAPII) subsequently recruiting NER
enzymes to the site of damage. Thus, DDB1, DDB2 and XPC are dis-
pensable for TC-NER. Groisman et al. could show that the CSN also
controls TC-NER [29]. As for DDB2 they demonstrated that CSA
forms an active CRL4A using DDB1 as adapter module. In contrast
to CRL4DDB2 the CRL4CSA complex is constitutively associated with
chromatin but bound to RNAPII in an UV-dependent manner. After
UV irradiation the hyperphosphorylated RNAPII (IIo) is rapidly
ubiquitinated [104,105] in wt cells but fails to be ubiquitinated
in CSA or CSB defective cells. Regardless of UV, the CSA complex
co-puriﬁes with RNAPII and accumulates on the hyperphosphoryl-
ated form of RNAPII (IIo), although ubiquitination has not been ob-
served under the conditions used in this study [29]. In HeLa cells,
CRL4CSA targets CSB for ubiquitination and degradation several
hours after UV irradiation suggesting a model in which the CRL4CSA
causes degradation of TC-NER components at the end of the repair
process so that transcription can resume [106]. In contrast, CSB and
CSA levels were reported to be unaltered under the same condi-
tions post-UV in primary wt and Cul4A deleted MEFs [101]. Unex-
pectedly, the CSN associated after UV irradiation with the CRL4ACSA
complex probably preventing ligase activity. However, no neddy-
lated CRL4ACSA complex was observed, neither before UV
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nor after UV irradiation.
Noteworthy, NER seems to be tightly controlled by c-Abl, a non-
receptor tyrosine kinase activated by e.g. IR but not UV irradiation,
which destabilizes DDB2 independently of its kinase activity [107].
Overexpression of c-Abl leads to phosphorylation of DDB2 inhibit-
ing its lesion binding activity suggesting a mechanism preventing
DDB2 from interference with other repair pathways [108]. Further-
more, c-Abl, together with other factors, seems to regulate the
CRL4A complex by reducing the Cul4A CAND1 interaction [107].
The mechanism behind this observation is still obscure.
3.3. The role of the CSN in checkpoint control
Checkpoints are surveillance mechanisms that ascertain the
ﬁdelity of the genome before progression in cell cycle. In response
to DNA damage the cell cycle is either slowed down or completely
arrested. Only after DNA repair the cell may regain the ability to
exit the arrest in a process called checkpoint recovery. In mamma-
lian cells there are two checkpoint signaling pathways each acti-
vated depending on the damage occurred. The damages are
sensed by proteins, e.g. RPA (binding to single stranded DNA),
Mre11-Rad50-Nbs1 (MRN) complex recognizing DSBs. Subse-
quently, sensor kinases (phosphoinositide 3-kinase related kinases,
PIKKs) are activated. UV-induced damage or replication fork stress
due to chemicals lead to activation of the sensor kinase ATR and
subsequent activation of checkpoint kinase 1 (Chk1). Phosphoryla-
tion of Chk1 depends on the Rad9-Rad1-Hus1 (9-1-1) complex that
is loaded on DNA. DSBs, e.g. caused by IR, induce ATM autophos-
phorylation and subsequently activate Chk2. Chk1 and Chk2 repre-
sent signal transducing kinases that have many substrates and
affect the activity of a myriad of effector proteins, e.g. p53, Cdc25
and Cdc45. Phosphorylation of these proteins eventually inhibits
the Cdk2 and Cdc2, that resemble key kinases in cell cycle progres-
sion resulting in G1/S and G2/M arrest, respectively. Unlike ATM,
ATR and Chk1 are suggested to be indispensable for the cell cycle
due to the fact that ATR- or Chk1-deﬁcient mice die at early embry-
onic stage.
There is evidence that CSN5 interacts with the 9-1-1 complex, a
PCNA-like complex that is loaded on DNA after genotoxic damage.
Coimmunoprecipitation analyzes reveal a direct interaction of the
CSN with the Rad1 [109]. In the same study the authors could show
that CSN5 overexpression leads to proteasomal degradation of the
9-1-1 complex, although the stability of the 9-1-1 complex is not
altered by inhibition of CSN-associated kinases [109]. Because
the PCNA-like 9-1-1 complex is needed for Chk1 phosphorylation,
CSN5/Jab1 suppresses the checkpoint signaling activation and DNA
synthesis recovery after replication stress [109].
The CRL4ACDT2 is probably the best studied CRL4 ligase and has
been shown to ubiquitinate the DNA replication licensing factor
CDT1 constituting a new checkpoint [110]. CDT1 is a licensing fac-
tor that assembles on replication origins at the end of mitosis and
in G1 [110] to license DNA for replication. Aberrant CDT1 activity
leads to re-replication and polyploid nuclei. In S phase or after
UV-induced DNA damage CRL4CDT2 binds, in an PCNA-dependent
manner, to chromatin or to the DNA lesions, respectively, and
mediates CDT1 degradation [111]. Unexpectedly, Higa et al. could
show that CDT2 binds to Cul4 as well as to DDB1 and regulates
CDT1 proteolysis in response to DNA damage [111]. The CSN or
at least single subunits have been shown to be associated with
CRL4CDT2. Knockdown of either CSN5 or CSN2 did not alter CDT1
proteolysis after DNA damage [111]. Higa et al. hypothesize that
the deneddylating enzyme 1 (DEN1) may be involved in CDT1
proteolysis.
Recently, the CRL4CDT2 also has been shown to target PR-Set7/
Set8 for proteasomal degradation [112]. Set8 methylates histone4 on lysine 20 (H4K20) resulting in chromatin silencing and com-
paction, important for chromosome segregation in mitosis [113].
Noteworthy, Set8 degradation is mediated by two other ligases:
CRL1Skp2 and anaphase promoting complex/cyclosome (APC/
C)Cdh1 [114]. The latter has not yet been shown to be modiﬁed by
Nedd8 but it is also affected by the CSN [115]. Notably, CRL4ACDT2
also targets p21 for degradation [116,117]. Interestingly, all pro-
teins ubiquitinated by CRL4CDT2 require PCNA and contain an PCNA
interacting motif (PIP) that is required for CRL4CDT2-mediated deg-
radation [48]. This in concert with the fact that CDT2 binds to Cul4
suggest that the CRL4CDT2 ligase differs from other CRLs. PCNA has
to be seen as part of the recognition module of CRL4CDT2.
The tumor suppressor protein p53 is a key player in DDR as it is
stabilized and activated in response to DNA damage. The CSN has
direct impact on the tumor suppressor [65,66]. Induction of p53
leads to upregulation of the kinase inhibitor p21 which binds to
Cdk2 thereby inhibiting its activity. Thus, elevated p21 levels cause
G1/S arrest and allow time for the DNA repair prior replication of
the genome [118]. Interestingly, p21 also inhibits replication by
binding to PCNA contributing to S-phase checkpoint. The degrada-
tion of p21 is regulated by APC/CCDC20, CRL1Skp2 and CRL4Cdt2 li-
gases [116,117,119] and an Ub independent pathway was also
reported [120].
After completion of DNA repair checkpoint recovery leads to re-
gain of the ability to exit the arrest. Checkpoint recovery involves
UPS-mediated degradation of Cdc25A, clapsin, a checkpoint medi-
ator, and the mitosis inhibiting kinase Wee1 by CRL1b-TrCP [80],
which is also regulated by the CSN. Interestingly, in a large-scale
proteomic analysis of proteins phosphorylated in response to
DNA damage induced by c-irradiation CSN1, CSN3 and CSN7a were
identiﬁed as putative substrates for the ATM and ATR kinases
[121], which supports data published by Shiloh [73]. In summary,
at least at the effector level of DDR the CSN fundamentally modu-
lates the outcome as it inﬂuences most of the key players (e.g. p21,
p27 and p53).
3.4. Manipulation of the CSN in the DDR: possible clinical applications
DDR is thought to be a barrier for tumor development. Hence,
many tumors display defects in the DDR. These cells do not efﬁ-
ciently repair their genome and, therefore, are sensitive to chemi-
cals that induce DNA damage, which may lead to senescence or
apoptosis. Induction of apoptosis in tumor cells is the aim of ther-
apy. An important effector of DDR is the tumor suppressor p53.
Elevation of p53 suppresses tumor growth and induces apoptosis.
Curcumin and emodin have been shown previously in our labora-
tory to inhibit the CSN associated kinases [69] making tumor cells
more prone to apoptosis [70]. However, this approach is only
meaningful in tumors expressing wt p53. Moreover, the DDB2 pro-
motor harbors p53 binding sites and elevated p53 levels would
lead to higher DDB2 levels. Interestingly, DDB2 supports apoptosis
by regulating the levels of p21 [122].
It has been proposed that prevention of replication lesion repair
could speciﬁcally kill cancer cells [123]. Such a strategy could even
be more promising applied together with DNA damaging agents or
radiation therapy. In fact, several inhibitors that target DNA repair
pathways have been developed and are in clinical trials [123].
Knockdown of CSN5 has been shown to cause defects in DNA repair
[29]. Studies from Csn5 knockout MEFs have shown that deneddy-
lation function is important for proliferation. Csn5 null cells that
are reconstituted with a CSN5 deneddylation defective mutant
arrest in cell cycle at multiple stages [124]. Hence, blocking the
deneddylation function of the CSN could be beneﬁcial in cancer
therapy.
Due to the fact that lack of CRL4A complexes leads to elevated
levels of DDB2 at higher DNA GG-NER rate, pharmacological
2850 R. Hannß, W. Dubiel / FEBS Letters 585 (2011) 2845–2852inhibition of Cul4A-DDB1 has been proposed to be attractive for
preventing UV- and carcinogen-induced cancer [101]. Small mole-
cules inhibiting the interaction of CSN5 with the 9-1-1 complex
may lead to checkpoint activation after induction of replication
stress and may be beneﬁcial for cancer prevention.
Many viruses induce DDR, which can either be beneﬁcial for vir-
al replication or an obstacle to overcome. Furthermore, divergent
viruses (paramyxovirus, herpesvirus, lentivirus and hepadnavirus)
are known to hijack or target CRL4s suggesting importance in eva-
sion of immune defense and viral propagation. Several viruses
seem to disrupt CRL4s or hijacking them to target host cell proteins
to facilitate viral replication probably by causing an extended S
phase [48]. Thus, manipulating the CRL4–CSN interaction may be
beneﬁcial for antiviral therapy.
4. Conclusion
The CSN is not just a deneddylase. CSN-mediated deneddyla-
tion, phosphorylation and deubiquitination affect multiple events
of DDR. Through regulating the activity of CRL ligases it has been
shown to be unequivocally involved in NER. Furthermore, via phos-
phorylation the CSN directly controls the stability of many impor-
tant proteins acting as effectors within the DDR. Thus, the CSN
most likely regulates the DDR outcome, whether the cell goes into
apoptosis or becomes senescent or recovers from damage.
In DDR the CSN may act as a platform arranging protein com-
munication. This is illustrated by the fact that after UV irradiation
the CSN dissociates from CRL4ADDB2 and subsequently forms a new
supercomplex by associating with CRL4ACSA. How this selective
reassembly and the formation of CSN-based supercomplexes are
regulated might be a main question in DDR research.
Another important question that has been raised is the feature
of CRL4DDB2 to cause mono-ubiquitination of histones but poly-
ubiquitination of other proteins.
Since many tumors display defects in DDR and the CSN has a
pivotal role in the process, manipulation of CSN activities will be
attractive for future tumor therapy.
Acknowledgements
We thank Tilo Schmaler for critical reading of the manuscript.
This work was funded by the Priority Program 1365 of the Deut-
sche Forschungsgemeinschaft.References
[1] Chamovitz, D.A., Wei, N., Osterlund, M.T., von Arnim, A.G., Staub, J.M., Matsui,
M. and Deng, X.W. (1996) The COP9 complex, a novel multisubunit nuclear
regulator involved in light control of a plant developmental switch. Cell 86,
115–121.
[2] Seeger, M. et al. (1998) A novel protein complex involved in signal
transduction possessing similarities to 26S proteasome subunits. FASEB J.
12, 469–478.
[3] Wei, N. and Deng, X.W. (1998) Characterization and puriﬁcation of the
mammalian COP9 complex, a conserved nuclear regulator initially identiﬁed
as a repressor of photomorphogenesis in higher plants. Photochem.
Photobiol. 68, 237–241.
[4] Wee, S., Hetfeld, B., Dubiel, W. and Wolf, D.A. (2002) Conservation of the
COP9/signalosome in budding yeast. BMC Genet. 3, 15.
[5] Maytal-Kivity, V., Pick, E., Piran, R., Hofmann, K. and Glickman, M.H. (2003)
The COP9 signalosome-like complex in S. cerevisiae and links to other PCI
complexes. Int. J. Biochem. Cell Biol. 35, 706–715.
[6] Mundt, K.E. et al. (1999) The COP9/signalosome complex is conserved in
ﬁssion yeast and has a role in S phase. Curr. Biol. 9, 1427–1430.
[7] Busch, S., Eckert, S.E., Krappmann, S. and Braus, G.H. (2003) The COP9
signalosome is an essential regulator of development in the ﬁlamentous
fungus Aspergillus nidulans. Mol. Microbiol. 49, 717–730.
[8] Pintard, L., Kurz, T., Glaser, S., Willis, J.H., Peter, M. and Bowerman, B. (2003)
Neddylation and deneddylation of CUL-3 is required to target MEI-1/Katanin
for degradation at the meiosis-to-mitosis transition in C. elegans. Curr. Biol.
13, 911–921.[9] Freilich, S., Oron, E., Kapp, Y., Nevo-Caspi, Y., Orgad, S., Segal, D. and
Chamovitz, D.A. (1999) The COP9 signalosome is essential for development of
Drosophila melanogaster. Curr. Biol. 9, 1187–1190.
[10] Glickman, M.H. et al. (1998) A subcomplex of the proteasome regulatory
particle required for ubiquitin-conjugate degradation and related to the
COP9–signalosome and eIF3. Cell 94, 615–623.
[11] Wei, N. and Deng, X.W. (1999) Making sense of the COP9 signalosome. A
regulatory protein complex conserved from Arabidopsis to human. Trends
Genet. 15, 98–103.
[12] Pick, E., Hofmann, K. and Glickman, M.H. (2009) PCI complexes: beyond the
proteasome, CSN, and eIF3 Troika. Mol. Cell 35, 260–264.
[13] Hofmann, K. and Bucher, P. (1998) The PCI domain: a common theme in three
multiprotein complexes. Trends Biochem. Sci. 23, 204–205.
[14] Deng, X.W. et al. (2000) Uniﬁed nomenclature for the COP9 signalosome and
its subunits: an essential regulator of development. Trends Genet. 16, 202–
203.
[15] Kato, J.Y. and Yoneda-Kato, N. (2009) Mammalian COP9 signalosome. Genes
Cells 14, 1209–1225.
[16] Wei, N., Serino, G. and Deng, X.W. (2008) The COP9 signalosome: more than a
protease. Trends Biochem. Sci. 33, 592–600.
[17] Lima, J.F., Malavazi, I., von Zeska Kress Fagundes, M.R., Savoldi, M., Goldman,
M.H., Schwier, E., Braus, G.H. and Goldman, G.H. (2005) The csnD/csnE
signalosome genes are involved in the Aspergillus nidulans DNA damage
response. Genetics 171, 1003–1015.
[18] Tomoda, K., Yoneda-Kato, N., Fukumoto, A., Yamanaka, S. and Kato, J.Y. (2004)
Multiple functions of jab1 are required for early embryonic development and
growth potential in mice. J. Biol. Chem. 279, 43013–43018.
[19] Lykke-Andersen, K., Schaefer, L., Menon, S., Deng, X.W., Miller, J.B. andWei, N.
(2003) Disruption of the COP9 signalosome Csn2 subunit in mice causes
deﬁcient cell proliferation, accumulation of p53 and cyclin E, and early
embryonic death. Mol. Cell. Biol. 23, 6790–6797.
[20] Yan, J. et al. (2003) COP9 signalosome subunit 3 is essential for maintenance
of cell proliferation in the mouse embryonic epiblast. Mol. Cell. Biol. 23,
6798–6808.
[21] Menon, S., Chi, H., Zhang, H., Deng, X.W., Flavell, R.A. andWei, N. (2007) COP9
signalosome subunit 8 is essential for peripheral T cell homeostasis and
antigen receptor-induced entry into the cell cycle from quiescence. Nat.
Immunol. 8, 1236–1245.
[22] Deshaies, R.J. and Joazeiro, C.A. (2009) RING domain E3 ubiquitin ligases.
Annu. Rev. Biochem. 78, 399–434.
[23] Petroski, M.D. and Deshaies, R.J. (2005) Function and regulation of cullin-
RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9–20.
[24] Chamovitz, D.A. (2009) Revisiting the COP9 signalosome as a transcriptional
regulator. EMBO Rep. 10, 352–358.
[25] Mundt, K.E., Liu, C. and Carr, A.M. (2002) Deletion mutants in COP9/
signalosome subunits in ﬁssion yeast Schizosaccharomyces pombe display
distinct phenotypes. Mol. Biol. Cell 13, 493–502.
[26] Liu, C., Powell, K.A., Mundt, K., Wu, L., Carr, A.M. and Caspari, T. (2003) COP9/
signalosome subunits and Pcu4 regulate ribonucleotide reductase by both
checkpoint-dependent and -independent mechanisms. Genes Dev. 17, 1130–
1140.
[27] Wang, J., Hu, Q., Chen, H., Zhou, Z., Li, W., Wang, Y., Li, S. and He, Q. (2010)
Role of individual subunits of the Neurospora crassa CSN complex in
regulation of deneddylation and stability of cullin proteins. PLoS Genet. 6,
e1001232.
[28] Oron, E., Mannervik, M., Rencus, S., Harari-Steinberg, O., Neuman-Silberberg,
S., Segal, D. and Chamovitz, D.A. (2002) COP9 signalosome subunits 4 and 5
regulate multiple pleiotropic pathways in Drosophila melanogaster.
Development 129, 4399–4409.
[29] Groisman, R. et al. (2003) The ubiquitin ligase activity in the DDB2 and CSA
complexes is differentially regulated by the COP9 signalosome in response to
DNA damage. Cell 113, 357–367.
[30] Yu, Z. et al. (2011) Dual function of Rpn5 in two PCI complexes, the 26S
proteasome and COP9 signalosome. Mol. Biol. Cell. 22, 911–920.
[31] Zhou, C., Arslan, F., Wee, S., Krishnan, S., Ivanov, A.R., Oliva, A., Leatherwood, J.
and Wolf, D.A. (2005) PCI proteins eIF3e and eIF3m deﬁne distinct translation
initiation factor 3 complexes. BMC Biol. 3, 14.
[32] Luke-Glaser, S., Roy, M., Larsen, B., Le Bihan, T., Metalnikov, P., Tyers, M.,
Peter, M. and Pintard, L. (2007) CIF-1, a shared subunit of the COP9/
signalosome and eukaryotic initiation factor 3 complexes, regulates MEL-
26 levels in the Caenorhabditis elegans embryo. Mol. Cell. Biol. 27, 4526–
4540.
[33] Gusmaroli, G., Figueroa, P., Serino, G. and Deng, X.W. (2007) Role of the MPN
subunits in COP9 signalosome assembly and activity, and their regulatory
interaction with Arabidopsis Cullin3-based E3 ligases. Plant Cell 19, 564–581.
[34] Wei, N. and Deng, X.W. (2003) The COP9 signalosome. Annu. Rev. Cell Dev.
Biol. 19, 261–286.
[35] Olma, M.H. et al. (2009) An interaction network of the mammalian COP9
signalosome identiﬁes Dda1 as a core subunit of multiple Cul4-based E3
ligases. J. Cell Sci. 122, 1035–1044.
[36] Kapelari, B., Bech-Otschir, D., Hegerl, R., Schade, R., Dumdey, R. and Dubiel,
W. (2000) Electron microscopy and subunit–subunit interaction studies
reveal a ﬁrst architecture of COP9 signalosome. J. Mol. Biol. 300, 1169–1178.
[37] Sharon, M., Mao, H., Boeri Erba, E., Stephens, E., Zheng, N. and Robinson, C.V.
(2009) Symmetrical modularity of the COP9 signalosome complex suggests
its multifunctionality. Structure 17, 31–40.
R. Hannß, W. Dubiel / FEBS Letters 585 (2011) 2845–2852 2851[38] Enchev, R.I., Schreiber, A., Beuron, F. and Morris, E.P. (2010) Structural
insights into the COP9 signalosome and its common architecture with the
26S proteasome lid and eIF3. Structure 18, 518–527.
[39] Cope, G.A., Suh, G.S., Aravind, L., Schwarz, S.E., Zipursky, S.L., Koonin, E.V. and
Deshaies, R.J. (2002) Role of predicted metalloprotease motif of Jab1/Csn5 in
cleavage of Nedd8 from Cul1. Science 298, 608–611.
[40] Berndt, C., Bech-Otschir, D., Dubiel, W. and Seeger, M. (2002) Ubiquitin
system: JAMMing in the name of the lid. Curr. Biol. 12, R815–R817.
[41] Yao, T. and Cohen, R.E. (2002) A cryptic protease couples deubiquitination
and degradation by the proteasome. Nature 419, 403–407.
[42] Finley, D. (2009) Recognition and processing of ubiquitin–protein conjugates
by the proteasome. Annu. Rev. Biochem. 78, 477–513.
[43] Verma, R., Aravind, L., Oania, R., McDonald, W.H., Yates 3rd, J.R., Koonin, E.V.
and Deshaies, R.J. (2002) Role of Rpn11 metalloprotease in deubiquitination
and degradation by the 26S proteasome. Science 298, 611–615.
[44] Wu, K. et al. (2003) DEN1 is a dual function protease capable of processing
the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. J. Biol.
Chem. 278, 28882–28891.
[45] Panattoni, M. et al. (2008) Targeted inactivation of the COP9 signalosome
impairs multiple stages of T cell development. J. Exp. Med. 205, 465–477.
[46] Adler, A.S., Lin, M., Horlings, H., Nuyten, D.S., van de Vijver, M.J. and Chang,
H.Y. (2006) Genetic regulators of large-scale transcriptional signatures in
cancer. Nat. Genet. 38, 421–430.
[47] Fukumoto, A. et al. (2004) Prognostic signiﬁcance of localized p27Kip1 and
potential role of Jab1/CSN5 in pancreatic cancer. Oncol. Rep. 11, 277–284.
[48] Jackson, S. and Xiong, Y. (2009) CRL4s: the CUL4-RING E3 ubiquitin ligases.
Trends Biochem. Sci. 34, 562–570.
[49] O’Connell, B.C. and Harper, J.W. (2007) Ubiquitin proteasome system (UPS):
what can chromatin do for you? Curr. Opin. Cell Biol. 19, 206–214.
[50] Lee, J. and Zhou, P. (2007) DCAFs, the missing link of the CUL4-DDB1
ubiquitin ligase. Mol. Cell 26, 775–780.
[51] Sowa, M.E., Bennett, E.J., Gygi, S.P. and Harper, J.W. (2009) Deﬁning the
human deubiquitinating enzyme interaction landscape. Cell 138, 389–403.
[52] Saha, A. and Deshaies, R.J. (2008) Multimodal activation of the ubiquitin
ligase SCF by Nedd8 conjugation. Mol. Cell 32, 21–31.
[53] Duda, D.M., Borg, L.A., Scott, D.C., Hunt, H.W., Hammel, M. and Schulman, B.A.
(2008) Structural insights into NEDD8 activation of cullin-RING ligases:
conformational control of conjugation. Cell 134, 995–1006.
[54] Lyapina, S. et al. (2001) Promotion of NEDD–CUL1 conjugate cleavage by
COP9 signalosome. Science 292, 1382–1385.
[55] Schwechheimer, C. et al. (2001) Interactions of the COP9 signalosome with
the E3 ubiquitin ligase SCFTIRI in mediating auxin response. Science 292,
1379–1382.
[56] Zhou, P. and Howley, P.M. (1998) Ubiquitination and degradation of the
substrate recognition subunits of SCF ubiquitin–protein ligases. Mol. Cell 2,
571–580.
[57] Galan, J.M. and Peter, M. (1999) Ubiquitin-dependent degradation of multiple
F-box proteins by an autocatalytic mechanism. Proc. Natl. Acad. Sci. USA 96,
9124–9129.
[58] Kao, W.H., Beaudenon, S.L., Talis, A.L., Huibregtse, J.M. and Howley, P.M.
(2000) Human papillomavirus type 16 E6 induces self-ubiquitination of the
E6AP ubiquitin–protein ligase. J. Virol. 74, 6408–6417.
[59] Schmidt, M.W., McQuary, P.R., Wee, S., Hofmann, K. and Wolf, D.A. (2009) F-
box-directed CRL complex assembly and regulation by the CSN and CAND1.
Mol. Cell 35, 586–597.
[60] Goldenberg, S.J., Cascio, T.C., Shumway, S.D., Garbutt, K.C., Liu, J., Xiong, Y. and
Zheng, N. (2004) Structure of the Cand1–Cul1–Roc1 complex reveals
regulatory mechanisms for the assembly of the multisubunit cullin-
dependent ubiquitin ligases. Cell 119, 517–528.
[61] Uhle, S. et al. (2003) Protein kinase CK2 and protein kinase D are associated
with the COP9 signalosome. EMBO J. 22, 1302–1312.
[62] Huang, X., Wagner, E., Dumdey, R., Peth, A., Berse, M., Dubiel, W. and Berndt,
C. (2006) Phosphorylation by COP9 signalosome-associated CK2 promotes
degradation of p27 during the G1 cell cycle phase. Isr. J. Chem. 46, 231–238.
[63] Sun, Y., Wilson, M.P. and Majerus, P.W. (2002) Inositol 1,3,4-trisphosphate 5/
6-kinase associates with the COP9 signalosome by binding to CSN1. J. Biol.
Chem. 277, 45759–45764.
[64] Bech-Otschir, D., Kapelari, B. and Dubiel, W. (2005) in: (Mayer, J.R.,
Ciechanover, A. and Rechsteiner, M., Eds.), Ubiquitin and the Chemistry of
Life, vol. 1, pp. 348–369, Wiley–VCH Verlag GmbH & KGaA, Weinheim.
[65] Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C.
and Dubiel, W. (2001) COP9 signalosome-speciﬁc phosphorylation targets
p53 to degradation by the ubiquitin system. EMBO J. 20, 1630–1639.
[66] Sun, L., Shi, L., Wang, F., Huangyang, P., Si, W., Yang, J., Yao, Z. and Shang, Y.
(2010) Substrate phosphorylation and feedback regulation in JFK-promoted
p53 destabilization. J. Biol. Chem. 286, 4226–4235.
[67] Peth, A., Boettcher, J.P. and Dubiel, W. (2007) Ubiquitin-dependent
proteolysis of the microtubule end-binding protein 1, EB1, is controlled by
the COP9 signalosome: possible consequences for microtubule ﬁlament
stability. J. Mol. Biol. 368, 550–563.
[68] Pollmann, C., Huang, X., Mall, J., Bech-Otschir, D., Naumann, M. and Dubiel,
W. (2001) The constitutive photomorphogenesis 9 signalosome directs
vascular endothelial growth factor production in tumor cells. Cancer Res.
61, 8416–8421.
[69] Fullbeck, M., Huang, X., Dumdey, R., Frommel, C., Dubiel, W. and Preissner, R.
(2005) Novel curcumin- and emodin-related compounds identiﬁed by insilico 2D/3D conformer screening induce apoptosis in tumor cells. BMC
Cancer 5, 97.
[70] Braumann, C., Tangermann, J., Jacobi, C.A., Muller, J.M. and Dubiel, W. (2008)
Novel anti-angiogenic compounds for application in tumor therapy – COP9
signalosome-associated kinases as possible targets. Mini Rev. Med. Chem. 8,
421–428.
[71] Karniol, B., Malec, P. and Chamovitz, D.A. (1999) Arabidopsis FUSCA5 encodes
a novel phosphoprotein that is a component of the COP9 complex. Plant Cell
11, 839–848.
[72] Huang, X., Langelotz, C., Hetfeld-Pechoc, B.K., Schwenk, W. and Dubiel, W.
(2009) The COP9 signalosome mediates beta-catenin degradation by
deneddylation and blocks adenomatous polyposis coli destruction via
USP15. J. Mol. Biol. 391, 691–702.
[73] Shiloh, Y. (2006) The ATM-mediated DNA-damage response: taking shape.
Trends Biochem. Sci. 31, 402–410.
[74] Zhou, C., Wee, S., Rhee, E., Naumann, M., Dubiel, W. and Wolf, D.A. (2003)
Fission yeast COP9/signalosome suppresses cullin activity through
recruitment of the deubiquitylating enzyme Ubp12p. Mol. Cell 11, 927–938.
[75] Hetfeld, B.K. et al. (2005) The zinc ﬁnger of the CSN-associated
deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1.
Curr. Biol. 15, 1217–1221.
[76] Wee, S., Geyer, R.K., Toda, T. and Wolf, D.A. (2005) CSN facilitates Cullin-RING
ubiquitin ligase function by counteracting autocatalytic adapter instability.
Nat. Cell Biol. 7, 387–391.
[77] Schweitzer, K., Bozko, P.M., Dubiel, W. and Naumann, M. (2007) CSN controls
NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J. 26, 1532–1541.
[78] Braus, G.H., Irniger, S. and Bayram, O. (2010) Fungal development and the
COP9 signalosome. Curr. Opin. Microbiol. 13, 672–676.
[79] Ciccia, A. and Elledge, S.J. (2010) The DNA damage response: making it safe to
play with knives. Mol. Cell 40, 179–204.
[80] Bartek, J. and Lukas, J. (2007) DNA damage checkpoints: from initiation to
recovery or adaptation. Curr. Opin. Cell Biol. 19, 238–245.
[81] Hong, E.J., Villén, J., Gerace, E.L., Gygi, S.P. and Moazed, D. (2005) A cullin E3
ubiquitin ligase complex associates with Rik1 and the Clr4 histone H3–K9
methyltransferase and is required for RNAi-mediated heterochromatin
formation. RNA Biol. 2, 106–111.
[82] Jia, S., Kobayashi, R. and Grewal, S.I. (2005) Ubiquitin ligase component Cul4
associates with Clr4 histone methyltransferase to assemble heterochromatin.
Nat. Cell Biol. 7, 1007–1013.
[83] Michel, J.J., McCarville, J.F. and Xiong, Y. (2003) A role for Saccharomyces
cerevisiae Cul8 ubiquitin ligase in proper anaphase progression. J. Biol. Chem.
278, 22828–22837.
[84] Luke, B., Versini, G., Jaquenoud, M., Zaidi, I.W., Kurz, T., Pintard, L., Pasero, P.
and Peter, M. (2006) The cullin Rtt101p promotes replication fork
progression through damaged DNA and natural pause sites. Curr. Biol. 16,
786–792.
[85] He, Y.J., McCall, C.M., Hu, J., Zeng, Y. and Xiong, Y. (2006) DDB1 functions as a
linker to recruit receptor WD40 proteins to CUL4–ROC1 ubiquitin ligases.
Genes Dev. 20, 2949–2954.
[86] Kapetanaki, M.G., Guerrero-Santoro, J., Bisi, D.C., Hsieh, C.L., Rapic´-Otrin, V.
and Levine, A.S. (2006) The DDB1–CUL4ADDB2 ubiquitin ligase is deﬁcient in
xeroderma pigmentosum group E and targets histone H2A at UV-damaged
DNA sites. Proc. Natl. Acad. Sci. USA 103, 2588–2593.
[87] Wang, H. et al. (2006) Histone H3 and H4 ubiquitylation by the CUL4–DDB–
ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol. Cell
22, 383–394.
[88] Sugasawa, K. (2009) The CUL4 enigma: culling DNA repair factors. Mol. Cell
34, 403–404.
[89] Friedberg, E.C. et al. (2006) DNA repair: from molecular mechanism to
human disease. DNA Repair (Amst.) 5, 986–996.
[90] Takedachi, A., Saijo, M. and Tanaka, K. (2010) DDB2 complex-mediated
ubiquitylation around DNA damage is oppositely regulated by XPC and
Ku and contributes to the recruitment of XPA. Mol. Cell. Biol. 30, 2708–
2723.
[91] Nouspikel, T. and Hanawalt, P.C. (2000) Terminally differentiated human
neurons repair transcribed genes but display attenuated global DNA repair
and modulation of repair gene expression. Mol. Cell. Biol. 20, 1562–1570.
[92] Nouspikel, T. and Hanawalt, P.C. (2002) DNA repair in terminally
differentiated cells. DNA Repair (Amst.) 1, 59–75.
[93] Yang, Y., Geldmacher, D.S. and Herrup, K. (2001) DNA replication precedes
neuronal cell death in Alzheimer’s disease. J. Neurosci. 21, 2661–2668.
[94] Reardon, J.T., Nichols, A.F., Keeney, S., Smith, C.A., Taylor, J.S., Linn, S. and
Sancar, A. (1993) Comparative analysis of binding of human damaged DNA-
binding protein (XPE) and Escherichia coli damage recognition protein (UvrA)
to the major ultraviolet photoproducts: T[c,s]T, T[t,s]T, T[6-4]T, and
T[Dewar]T. J. Biol. Chem. 268, 21301–21308.
[95] Fujiwara, Y., Masutani, C., Mizukoshi, T., Kondo, J., Hanaoka, F. and Iwai, S.
(1999) Characterization of DNA recognition by the human UV-damaged
DNA-binding protein. J. Biol. Chem. 274, 20027–20033.
[96] Chu, G. and Yang, W. (2008) Here comes the sun: recognition of UV-damaged
DNA. Cell 135, 1172–1174.
[97] Scrima, A. et al. (2008) Structural basis of UV DNA-damage recognition by the
DDB1–DDB2 complex. Cell 135, 1213–1223.
[98] Matsuda, N. et al. (2005) DDB2, the xeroderma pigmentosum group E gene
product, is directly ubiquitylated by Cullin 4A-based ubiquitin ligase
complex. DNA Repair (Amst.) 4, 537–545.
2852 R. Hannß, W. Dubiel / FEBS Letters 585 (2011) 2845–2852[99] Sugasawa, K. et al. (2005) UV-induced ubiquitylation of XPC protein
mediated by UV-DDB-ubiquitin ligase complex. Cell 121, 387–400.
[100] Hannah, J. and Zhou, P. (2009) Regulation of DNA damage response pathways
by the cullin-RING ubiquitin ligases. DNA Repair (Amst.) 8, 536–543.
[101] Liu, L. et al. (2009) CUL4A abrogation augments DNA damage response and
protection against skin carcinogenesis. Mol. Cell 34, 451–460.
[102] Wang, Q.E. et al. (2007) Ubiquitylation-independent degradation of
Xeroderma pigmentosum group C protein is required for efﬁcient
nucleotide excision repair. Nucleic Acids Res. 35, 5338–5350.
[103] Carreau, M. and Hunting, D. (1992) Transcription-dependent and
independent DNA excision repair pathways in human cells. Mutat. Res.
274, 57–64.
[104] Bregman, D.B., Halaban, R., van Gool, A.J., Henning, K.A., Friedberg, E.C. and
Warren, S.L. (1996) UV-induced ubiquitination of RNA polymerase II: a novel
modiﬁcation deﬁcient in Cockayne syndrome cells. Proc. Natl. Acad. Sci. USA
93, 11586–11590.
[105] Ratner, J.N., Balasubramanian, B., Corden, J., Warren, S.L. and Bregman, D.B.
(1998) Ultraviolet radiation-induced ubiquitination and proteasomal
degradation of the large subunit of RNA polymerase II. Implications for
transcription-coupled DNA repair. J. Biol. Chem. 273, 5184–5189.
[106] Groisman, R. et al. (2006) CSA-dependent degradation of CSB by the
ubiquitin–proteasome pathway establishes a link between
complementation factors of the Cockayne syndrome. Genes Dev. 20, 1429–
1434.
[107] Chen, X., Zhang, J., Lee, J., Lin, P.S., Ford, J.M., Zheng, N. and Zhou, P. (2006) A
kinase-independent function of c-Abl in promoting proteolytic destruction of
damaged DNA binding proteins. Mol. Cell 22, 489–499.
[108] Cong, F., Tang, J., Hwang, B.J., Vuong, B.Q., Chu, G. and Goff, S.P. (2002)
Interaction between UV-damaged DNA binding activity proteins and the c-
Abl tyrosine kinase. J. Biol. Chem. 277, 34870–34878.
[109] Huang, J., Yuan, H., Lu, C., Liu, X., Cao, X. and Wan, M. (2007) Jab1 mediates
protein degradation of the Rad9–Rad1–Hus1 checkpoint complex. J. Mol.
Biol. 371, 514–527.
[110] Higa, L.A., Mihaylov, I.S., Banks, D.P., Zheng, J. and Zhang, H. (2003) Radiation-
mediated proteolysis of CDT1 by CUL4–ROC1 and CSN complexes constitutes
a new checkpoint. Nat. Cell Biol. 5, 1008–1015.
[111] Higa, L.A., Banks, D., Wu, M., Kobayashi, R., Sun, H. and Zhang, H. (2006)
L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates
CDT1 proteolysis in response to DNA damage. Cell Cycle 5, 1675–1680.[112] Oda, H., Hubner, M.R., Beck, D.B., Vermeulen, M., Hurwitz, J., Spector, D.L. and
Reinberg, D. (2010) Regulation of the histone H4 monomethylase PR-Set7 by
CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage.
Mol. Cell 40, 364–376.
[113] Jorgensen, S. et al. (2011) SET8 is degraded via PCNA-coupled
CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J. Cell
Biol. 192, 43–54.
[114] Wu, S. and Rice, J.C. (2011) A new regulator of the cell cycle: the PR-Set7
histone methyltransferase. Cell Cycle 10, 68–72.
[115] Kob, R., Kelm, J., Posorski, N., Baniahmad, A., von Eggeling, F. and Melle, C.
(2009) Regulation of the anaphase-promoting complex by the COP9
signalosome. Cell Cycle 8, 2041–2049.
[116] Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M. and Dutta, A.
(2008) PCNA-dependent regulation of p21 ubiquitylation and degradation
via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 22, 2496–2506.
[117] Nishitani, H., Shiomi, Y., Iida, H., Michishita, M., Takami, T. and Tsurimoto, T.
(2008) CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-
coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J.
Biol. Chem. 283, 29045–29052.
[118] Sancar, A., Lindsey-Boltz, L.A., Unsal-Kaçmaz, K. and Linn, S. (2004) Molecular
mechanisms of mammalian DNA repair and the DNA damage checkpoints.
Annu. Rev. Biochem. 73, 39–85.
[119] Frescas, D. and Pagano, M. (2008) Deregulated proteolysis by the F-box
proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8,
438–449.
[120] Soria, G. and Gottifredi, V. (2010) PCNA-coupled p21 degradation after DNA
damage: the exception that conﬁrms the rule? DNA Repair (Amst.) 9, 358–
364.
[121] Matsuoka, S. et al. (2007) ATM and ATR substrate analysis reveals extensive
protein networks responsive to DNA damage. Science 316, 1160–1166.
[122] Stoyanova, T., Roy, N., Kopanja, D., Bagchi, S. and Raychaudhuri, P. (2009)
DDB2 decides cell fate following DNA damage. Proc. Natl. Acad. Sci. USA 106,
10690–10695.
[123] Helleday, T., Petermann, E., Lundin, C., Hodgson, B. and Sharma, R.A. (2008)
DNA repair pathways as targets for cancer therapy. Nat. Rev. Cancer 8, 193–
204.
[124] Yoshida, A., Yoneda-Kato, N., Panattoni, M., Pardi, R. and Kato, J.Y. (2010)
CSN5/Jab1 controls multiple events in the mammalian cell cycle. FEBS Lett.
584, 4545–4552.
